B1II43 AF NFT

Polyribonucleotide nucleotidyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigxoene3xs5bw6ud7n5vrsrdvgrraaqrsby3dhv676aqmpt76q4ue/metadata.json
IPFS of structure file: 
bafybeihbfggeaw5vp4lxvbzckc3w2gxhxellp27eaznptlczcur2yxitku/AF-B1II43-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5881B09f2D8e743400698633641fc1cD2Ed2BE6F
First NFT owner address (bech32): 
genesis1tzqmp8ed3e6rgqrfscekg87pe5hd90n0e7l5st
Current NFT ID #304153 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
304153
Accession (UniProt):
B1II43
Name::
Polyribonucleotide nucleotidyltransferase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Okra / Type B1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1II43 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1II43|PNP_CLOBK Polyribonucleotide nucleotidyltransferase OS=Clostridium botulinum (strain Okra / Type B1) OX=498213 GN=pnp PE=3 SV=1 MIHTLETTVAGRKMKVDFGKTGMLSNAAIFMSYGDTVVMINANASKEPREGIDFFPLSVDYEERLYSVGKIPGGFIKREGKPSDKSILHARSIDRPLRPLFPKGYRNDVQIVNTVLSVEQDNLPEILAINGSSLALCLSSIPFTTPVAAVSVGLVDGEFIINPTVAQRENTILDLTVCATKERVMMVEAGGQEIDEETMYSAIIFGFEECKNIVAFQEEAVAKFGKTKNEPVLYKADEEVEKEVKSFAFDMIKEAMYIMDKDERNAQLDKVKEKISEEFSEKYEDKGADIAEVIYKTQKEIVRNMLLNEDRRPDGRAFDEVRPISCEVGILPRTHGTGLFTRGLTQVMTVATLGALGDVQILDGIAEEESKRYMHHYNFPSYSVGEVRPLRGPGRREIGHGALAERALEPLIPSQEEFPYTIRLVSEVLSSNGSTSQASVCGSTLALLDAGVPIKRPAAGIAMGLITSEDLEKEKVITDIQGIEDFFGDMDFKVAGTEKGITSIQFDTKIKGLSNSCVKDALEGAKKARLHILGKIKECIPEPRKELSKYAPRTEIICIDPEKIRDVIGAGGKVINKIIADTNVKIEIKEDGKIFVTSNNEPEGVKKAISIIEGLTKEVVQGEIYLGKVTKTTNFGAFVEILPGKEGLVHISKLDFARVEKVEDVVSVGDEILVKVTDIDNQGRINLSRKDAIAKKEEEKDK